DAILY RESEARCH
As of 30 Jul 10
WEEKLY RESEARCH

Daily Economic Report
Daily Research Report
Technical Analysis
Daily Investment Guide
Hot Tips!


Weekly Economic Report
Samuel Trading Idea
Monthly Summary Valuation Report

BBNI - Good efficiency and strong fee income

29 Jul 10

Bank Negara Indonesia (BBNI) – Maintain BUY
Price: Rp3,000 – Target Price: Rp3,450

Good efficiency and strong fee income

•    Net interest income and net income in 1H10 rose by 9.5% and 60.8% YoY respectively, translation to 47.5%-52.2% of our estimates
•    Excess liquidity increase significantly (+49%), we see the excess liquidity could be a buffer for undisbursed loan
•    Strong fee income due to recovery loan as much as Rp849 bn
•    Proportion of CASA increased to 60% from 54%
•    Maintain our BUY recommendation with price target Rp3,450/share


BBNI_100729_jp.pdf

Expected 1H10 Result

29 Jul 10

Kalbe Farma (KLBF) – Maintain BUY
Price: Rp2,450 – Target Price: Rp2,600

Expected 1H10 result

•    Revenue and net income in 1H10 rose by 11.6% and 43.5% YoY respectively, in line with our estimates.
•    Net margin improved to 12.2% (from 9.5%) and operating margin at 17.8% (from 16.6%).
•    Net income growth due to stronger Rupiah that caused lower COGS and reduced forex loss.
•    KLBF still maintained strong balance sheet with net cash of Rp1.3 trillion.
•    Maintain Buy recommendation, TP Rp2,600/share.
 


KLBF_100729_YY.pdf

BMRI - Solid Performance

28 Jul 10

Bank Mandiri (BMRI) – Maintain BUY
Price: Rp6,150 – Target Price: Rp7,100

Solid Performance

•    Net interest income and net income BMRI in 1H10 rose by 8.2% and 37.3% YoY respectively, in line with our estimates
•    Loan grew by 20% but net interest income fell due to decrease in bond yield and foreign loan yield
•    Net income growth supported by fee income, cash recovery, and efficiency
•    Deposit is targeted to grow by 11%, because strong liquidity
•    Maintain Buy recommendation, TP Rp7,100/share


BMRI_100727_jp.pdf